Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Noncovalent Attractions in Biomolecules02:35

Noncovalent Attractions in Biomolecules

Noncovalent attractions are associations within and between molecules that influence the shape and structural stability of complexes. These interactions differ from covalent bonding in that they do not involve sharing of electrons.
Four types of noncovalent interactions are hydrogen bonds, van der Waals forces, ionic bonds, and hydrophobic interactions.
Hydrogen bonding results from the electrostatic attraction of a hydrogen atom covalently bonded to a strong-electronegative atom like oxygen,...
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein and Protein Structure02:15

Protein and Protein Structure

Proteins are one of the most abundant organic molecules in living systems and have the most diverse range of functions of all macromolecules. Proteins may be structural, regulatory, contractile, or protective. They may serve in transport, storage, or membranes; or they may be toxins or enzymes. Their structures, like their functions, vary greatly. They are all, however, amino acid polymers arranged in a linear sequence.
A protein's shape is critical to its function. For example, an enzyme can...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A broad-spectrum inhibitor of copper-exporting P<sub>1B</sub>-type ATPases.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

MAP3K1: A Multifunctional Kinase at the Crossroads of Cancer Progression and Tumor Suppression.

Cells·2026
Same author

CXCR1 and CXCR2 display receptor bias for shared chemokine agonists.

Molecular pharmacology·2026
Same author

A First-In-Class Broad Spectrum Inhibitor of Copper Exporting P<sub>1B</sub>-type ATPases.

bioRxiv : the preprint server for biology·2026
Same author

Structural Basis of Chemokine CXCL8 Monomer and Dimer Binding to Chondroitin Sulfate: Insights into Specificity and Plasticity.

Biomolecules·2026
Same author

l-Theanine attenuates intestinal oxidative injury in mice through modulation of ferroptosis pathways.

The Journal of nutritional biochemistry·2026

Related Experiment Video

Updated: Jun 16, 2026

The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)
07:22

The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)

Published on: January 12, 2024

Structural characterization of BRCT-tetrapeptide binding interactions.

Prem Raj B Joseph1, Ziyan Yuan, Eric A Kumar

  • 1Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, 77555, USA.

Biochemical and Biophysical Research Communications
|February 4, 2010
PubMed
Summary
This summary is machine-generated.

The BRCA1 BRCT domain binds DNA repair targets via a pSXXF motif. This study reveals how these interactions involve dynamic structural changes, crucial for designing effective inhibitors.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Identifying Protein-protein Interaction Sites Using Peptide Arrays
07:44

Identifying Protein-protein Interaction Sites Using Peptide Arrays

Published on: November 18, 2014

Related Experiment Videos

Last Updated: Jun 16, 2026

The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)
07:22

The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)

Published on: January 12, 2024

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Identifying Protein-protein Interaction Sites Using Peptide Arrays
07:44

Identifying Protein-protein Interaction Sites Using Peptide Arrays

Published on: November 18, 2014

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • The BRCA1 BRCT domain is essential for DNA repair.
  • It recognizes the phosphoserine-phenylalanine (pSXXF) motif in target proteins.
  • Understanding this interaction is key for developing targeted therapies.

Purpose of the Study:

  • To characterize the binding interactions between the BRCT domain and pSXXF tetrapeptides.
  • To elucidate the structural and dynamic basis of this molecular recognition.
  • To provide insights for designing high-affinity BRCT inhibitors.

Main Methods:

  • Nuclear Magnetic Resonance (NMR) spectroscopy.
  • Isothermal Titration Calorimetry (ITC).

Main Results:

  • The BRCT domain is dynamic and gains structure upon binding to pSXXF tetrapeptides.
  • Phosphoserine and phenylalanine residues are critical for binding specificity and affinity.
  • Binding affinity is directly correlated with coupled structural and dynamic changes in both the protein and peptide.

Conclusions:

  • The binding mechanism of BRCT domains involves significant conformational changes.
  • The pSXXF motif interaction is finely tuned by structural dynamics.
  • These findings are vital for the rational design of novel BRCT inhibitors for therapeutic applications.